Madrigal Pharmaceuticals, Inc.
Symbol: MDGL
NASDAQ
229.84
USDDzisiejsza cena rynkowa
-12.1269
Wskaźnik P/E
-0.3892
Wskaźnik PEG
4.83B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Madrigal Pharmaceuticals, Inc. (MDGL) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1494.38 | 634.1 | 358.8 | 270.3 | ||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1141.9 | 534.2 | 27.2 | 234.1 | ||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.other-current-assets | 11.25 | 3.1 | 2.6 | 1.3 | ||||||||||||||||||||||
balance-sheet.row.total-current-assets | 1505.63 | 637.3 | 361.4 | 271.7 | ||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 7.79 | 3.3 | 1.2 | 1.6 | ||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 7.79 | 3.3 | 1.2 | 1.6 | ||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.total-assets | 1513.42 | 640.5 | 362.6 | 273.3 | ||||||||||||||||||||||
balance-sheet.row.account-payables | 74.25 | 28 | 23.8 | 21.4 | ||||||||||||||||||||||
balance-sheet.row.short-term-debt | 2.1 | 0.5 | 0.6 | 0.4 | ||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 414.74 | 115.5 | 49.3 | 0.4 | ||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||
balance-sheet.row.other-current-liab | 339.92 | 90 | 91.5 | 55 | ||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 415.93 | 116.7 | 49.3 | 0.4 | ||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 4.09 | 1.2 | 0.6 | 0.8 | ||||||||||||||||||||||
balance-sheet.row.total-liab | 832.2 | 235.2 | 165.2 | 77.2 | ||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.retained-earnings | -4725.3 | -1336.3 | -962.7 | -667.3 | ||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0.25 | 0.5 | 0 | -0.1 | ||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 5406.26 | 1741.2 | 1160.1 | 863.5 | ||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 681.22 | 405.3 | 197.4 | 196.1 | ||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1513.42 | 640.5 | 362.6 | 273.3 | ||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
balance-sheet.row.total-equity | 681.22 | 405.3 | 197.4 | 196.1 | ||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1513.42 | - | - | - | ||||||||||||||||||||||
Total Investments | 1141.9 | 534.2 | 27.2 | 234.1 | ||||||||||||||||||||||
balance-sheet.row.total-debt | 418.03 | 117.2 | 49.9 | 0.8 | ||||||||||||||||||||||
balance-sheet.row.net-debt | 65.56 | 17.3 | -281.7 | -35.5 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -373.63 | -373.6 | -295.4 | -241.8 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.53 | 0.5 | 0.5 | 0.4 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | -3.64 | -4.2 | 0 | -7.3 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 49.73 | 49.7 | 31.6 | 26.9 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | -3.28 | -3.3 | 37.6 | 30.7 | |||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.account-payables | 4.21 | 4.2 | 2.5 | 20.4 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 11.49 | -7.5 | 35.2 | 10.3 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 6.05 | 6.6 | 0.8 | 7.3 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -324.23 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1.48 | -1.5 | -0.2 | -0.2 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | -1.85 | -5.5 | 0 | 0.8 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | -834.44 | -834.4 | -143.5 | -394.1 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 333.4 | 333.4 | 350.4 | 389.3 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | 1.85 | 5.5 | 0 | -0.8 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -502.52 | -502.5 | 206.7 | -5.1 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -64.64 | -64.6 | -49.1 | 0 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 504.4 | 530.5 | 255.4 | 170.2 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | 155.83 | 129.3 | 107.2 | 1 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 595.12 | 595.1 | 313.5 | 171.2 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 58.06 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | -231.63 | -231.6 | 295.3 | -17.7 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 352.47 | 99.9 | 331.5 | 36.3 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 584.11 | 331.5 | 36.3 | 54 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | -324.23 | -324.2 | -224.9 | -183.9 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -1.48 | -1.5 | -0.2 | -0.2 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | -325.71 | -325.7 | -225.1 | -184.1 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0.53 | 0.5 | 0.5 | 0.4 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | -0.53 | -0.5 | -0.5 | -0.4 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 272.21 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 108.15 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0.3 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 380.35 | 380 | 293.6 | 242.5 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 380.5 | 380.5 | 293.6 | 242.5 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 19.58 | 19.6 | 2.2 | 0.4 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 5.7 | 12.7 | 4 | 0 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 6.87 | 6.9 | -1.8 | 0.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0.3 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 6.87 | 6.9 | -1.8 | 0.6 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 5.7 | 12.7 | 4 | 0 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 4.3 | 0.5 | 2.2 | 0.4 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -372.9 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | -380.5 | -380.5 | -293.6 | -242.5 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | -373.63 | -373.6 | -295.4 | -241.8 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 4.19 | 0 | 4 | -0.8 | |||||||||||||||||||||||
income-statement-row.row.net-income | -374.53 | -373.6 | -299.3 | -241.1 |
Często zadawane pytania
Ile wynosi Madrigal Pharmaceuticals, Inc. (MDGL) aktywów ogółem?
Madrigal Pharmaceuticals, Inc. (MDGL) całkowite aktywa to 640547000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.000.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -16.483.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.000.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.000.
Co to jest Madrigal Pharmaceuticals, Inc. (MDGL) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -373630000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 117193000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 379969000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 99915000.000.